Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Lysyl oxidase-like 2 inhibition ameliorated podocyte fibrosis by inhibiting transforming growth factor-beta signaling under high-glucose conditions: Nara Jeon, Beom Jin Lim, Hoon Young Choi; Received April 10, 2025 Accepted May 18, 2025 Published online September 30, 2025; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Applicability of current chronic kidney disease criteria for mortality and end-stage kidney disease in older diabetic populations: Kyungho Lee, Subin Hwang, Jeeeun Park et al.; Received December 2, 2024 Accepted February 23, 2025 Published online August 11, 2025; [Epub ahead of print]; Full text PubReader ePub PDF

Integrated genomics and metabolomics to identify cause-specific biomarkers for chronic kidney disease in a Korean population: Min Woo Kang, Ji-Eun Kim, Jihyun Kang et al.; Kidney Res Clin Pract. 2026;45(1):50-64. Published online June 2, 2025; DOI: https://doi.org/10.23876/j.krcp.24.135; Full text PubReader ePub PDF Supplementary Material

Pericyte activation accompanied by peritubular capillaries dysfunction and pericyte-to-myofibroblast transition is associated with renal fibrosis in diabetic nephropathy: Yiduo Feng, Dongli Tian, Yu Bai et al.; Kidney Res Clin Pract. 2025;44(6):928-940. Published online February 6, 2024; DOI: https://doi.org/10.23876/j.krcp.23.099
Web of Science 5 Cited By 9; Full text PubReader ePub PDF Supplementary Material

Special Articles

Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future: Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha et al.; Kidney Res Clin Pract. 2024;43(1):8-19. Published online January 31, 2024; DOI: https://doi.org/10.23876/j.krcp.23.232
Web of Science 10 Cited By 12; Full text PubReader ePub PDF

Original Articles

Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus: Wook-Joon Kim, Taehoon Oh, Nam Hun Heo et al.; Kidney Res Clin Pract. 2025;44(1):91-101. Published online January 12, 2024; DOI: https://doi.org/10.23876/j.krcp.23.059
Web of Science 6 Cited By 5; Full text PubReader ePub PDF

Long non-coding RNA MEG3 silencing weakens high glucose-induced mesangial cell injury by decreasing LIN28B expression by sponging and sequestering miR-23c: Lu Rong, Huanzhou Xue, Jianwei Hao, Jianjun Liu, Hao Xu; Kidney Res Clin Pract. 2024;43(5):600-613. Published online December 11, 2023; DOI: https://doi.org/10.23876/j.krcp.23.090
Web of Science 3 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance: Soie Kwon, Jin Seong Hyeon, Youngae Jung et al.; Kidney Res Clin Pract. 2023;42(4):445-459. Published online July 25, 2023; DOI: https://doi.org/10.23876/j.krcp.22.152
Web of Science 19 Cited By 18; Full text PubReader ePub PDF Supplementary Material

Review Articles

Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease: Jihyun Baek, Yu Ho Lee, Hye Yun Jeong, So-Young Lee; Kidney Res Clin Pract. 2023;42(5):546-560. Published online May 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.233
Web of Science 12 Cited By 12; Full text PubReader ePub PDF

Novel biomarkers for diabetic kidney disease: Chan-Young Jung, Tae-Hyun Yoo; Kidney Res Clin Pract. 2022;41(Suppl 2):S46-S62. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.22.084
Web of Science 12 Cited By 10; Full text PubReader ePub PDF

Original Articles

Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy: Taeyeong Kim, Yooujin Kwak, Jun Young Lee et al.; Kidney Res Clin Pract. 2022;41(5):545-555. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.22.123
Web of Science 4 Cited By 5; Full text PubReader ePub PDF

Weight change and risk of depression in patients with diabetic kidney disease: a nationwide population-based study: Hong Sang Choi, Bongseong Kim, Kyung-Do Han et al.; Kidney Res Clin Pract. 2023;42(1):86-97. Published online September 8, 2022; DOI: https://doi.org/10.23876/j.krcp.21.294
Web of Science 4 Cited By 5; Full text PubReader ePub PDF Supplementary Material

Review Articles

NADPH oxidase inhibitor development for diabetic nephropathy through water tank model: Hye Eun Lee, Seunghwan Shim, Yongseok Choi, Yun Soo Bae; Kidney Res Clin Pract. 2022;41(Suppl 2):S89-S98. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.21.269
Web of Science 8 Cited By 8; Full text PubReader ePub PDF

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors: Anthony T. P. Chan, Sydney C. W. Tang; Kidney Res Clin Pract. 2022;41(6):682-698. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.21.285
Web of Science 7 Cited By 6; Full text PubReader ePub PDF

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions: Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo; Kidney Res Clin Pract. 2022;41(2):136-149. Published online March 25, 2022; DOI: https://doi.org/10.23876/j.krcp.22.001
Web of Science 63 Cited By 63; Full text PubReader ePub PDF

Volume 45, No. 1

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.8

MOST VIEWED MOST CITED

25,739	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
8,757	Management of high-flow arteriovenous access
4,435	Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis
6,968	Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension
7,774	Precision medicine for focal segmental glomerulosclerosis

Cited By 12	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 11	Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System
Cited By 11	School urinary screening program in Japan: history, outcomes, perspectives
Cited By 11	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury
Cited By 11	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2026 by The Korean Society of Nephrology.